Os vasos sanguíneos são formados, entre outros componentes, por células endoteliais as quais fazem parte da microvasculatura óssea e são capazes de regular o desenvolvimento ósseo tendo em vista de que os processos de osteogênese e angiogênese estão interligados. Os leucotrienos (LTs) são mediadores lipídicos envolvidos no recrutamento de leucócitos e na regulação da síntese de citocinas. O tratamento com o leucotrieno B4 (LTB4) induz a angiogênese pela superexpressão do fator de crescimento endotelial vascular (VEGF). Assim, o objetivo do trabalho foi investigar o efeito das células endoteliais reguladas pelo LTB4 na diferenciação osteogênica. Para isso, células endoteliais primárias de aorta foram isoladas e cultivadas por até 4 dias e, quando apropriado, foi realizado o tratamento das mesmas com o LTB4. O meio condicionado das células endoteliais foi armazenado para os experimentos com osteoblastos. Células osteoblásticas foram isoladas da calvária e cultivadas por até 21 dias, avaliando-se, portanto, os efeitos das células endoteliais reguladas ou não pelo LTB4 e a resposta dos estímulos exógenos LTB4, o inibidor da síntese de LTs MK 886 e o antagonista do receptor do LTB4, o U75302. Tais respostas foram observadas na fase de crescimento celular, por meio da viabilidade, proliferação e produção de marcadores osteogênicos e angiogênicos como o RANKL, OPG e o VEGF por meio da redução do MTT, citometria de fluxo e western blotting, respectivamente. A diferenciação foi avaliada por meio dos ensaios de fosfatase alcalina (ALP) e expressão gênica por meio de ensaio enzimático e qRT-PCR e mineralização por Vermelho de alizarina. Resultados mostraram que tanto as células endoteliais, mediadas ou não pelo LTB4, quanto os estímulos exógenos não foram capazes de modular a proliferação dos osteoblastos. Porém, durante a diferenciação, o LTB4 inibiu a atividade da ALP, a expressão gênica do BLT1, ALP, BGLAP (osteocalcina) e OPG (osteoprotegerina) foi aumentada, e os genes RANKL e VEGF tiveram a sua expressão diminuída pelo tratamento com o meio condicionado das células endoteliais, mediadas ou não pelo LTB4 (P<0,05). Além disso, a mineralização dos osteoblastos foi aumentada pelas células endoteliais e diminuída pelas células endoteliais mediadas pelo LTB4 (P<0,05). Assim, podemos concluir que os fatores angiogênicos das células endoteliais, mediadas ou não pelo LTB4, exercem um papel importante na regulação da diferenciação osteogênica e formação óssea contribuindo, portanto, para a compreensão de mecanismos que regulam a patofisiologia de doenças ósseas. / Endothelial cells make blood vessels and are involved in the regulation of tissue metabolism. Endothelial cells from bone microvasculature are capable of regulating bone development in view of the fact that the processes of osteogenesis and angiogenesis are interconnected. Leukotrienes (LTs) are lipid mediators involved in leukocyte recruitment and regulation of cytokine synthesis. It is known that the treatment with LTB4 induces angiogenesis by overexpression of vascular endothelial growth factor (VEGF). Thus, the aim of this study was to investigate the effect of LTB4-regulated endothelial cells on osteogenic differentiation. For this, primary endothelial cells from aorta were isolated and cultured for up to 4 days and, where appropriate, the treatment with LTB4 was done. The conditioned medium of these cells was stored for osteoblast experiments. Osteoblastic cells were isolated from calvaria and cultured for up to 21 days, assessing the effects of endothelial cells regulated or not by LTB4 and the response of exogenous LTB4 stimuli, the inhibitor of LTs synthesis MK 886 and the antagonist of LTB4 receptor, U75302. Such responses were observed in the cell growth phase through the viability, proliferation and production of osteogenic and angiogenic markers such as RANKL, OPG and VEGF by MTT assay, flow cytometry and western blotting, respectively. The cell differentiation was evaluated by alkaline phosphatase (ALP), gene expression and mineralization assay through ALP enzymatic assay, qRT-PCR and Alizarin Red staining. Results showed that both endothelial cells, mediated or not by LTB4 and exogenous stimuli were not able to modulate the osteoblasts proliferation. However, during the differentiation, LTB4 inhibited ALP activity, the gene expression of BLT1, ALP, BGLAP (osteocalcin) and OPG (osteoprotegerin) was increased, and the RANKL and VEGF genes had their expression decreased by the treatment with the endothelial cells conditioned medium, mediated or not by LTB4 (P <0.05). In addition, the osteoblasts mineralization was increased by endothelial cells conditioned medium (CM-EC) and decreased by LTB4-mediated endothelial cells conditioned medium (CM-EC-LTB4) (P <0.05). Thus, we can conclude that the angiogenic factors of the endothelial cells, mediated or not by LTB4, play an important role in the regulation of osteogenic differentiation and bone formation, thus contributing to the understanding of mechanisms that regulate the pathophysiology of bone diseases.

Em Implantodontia, o titânio (Ti) é o material de escolha para a confecção dos implantes dentários por apresentar excelentes propriedades mecânicas e biocompatibilidade. Entretanto, novas estratégias de modificações da topografia e da composição bioquímica da superfície de Ti vêm sendo pesquisadas com o objetivo de incrementar a biocompatibilidade do Ti. A combinação de alterações topográficas em escala nanométrica e revestimento com o colágeno tipo I seria uma modificação com potencial para aumentar e/ou acelerar o processo de osseointegração. Assim, o objetivo desse estudo foi avaliar o efeito de superfície de Ti com nanotopografia revestida com colágeno sobre a osteogênese in vitro. Para isso, osteoblastos derivados de calvária de ratos foram cultivados em meio osteogênico sobre 4 superfícies de Ti: usinada (Ti Usi), usinada revestida com colágeno (Ti Usi/Col), com nanotopografia (Ti Nano) e com nanotopografia revestida com colágeno (Ti Nano/Col). A osteogênese foi avaliada pelos seguintes parâmetros: viabilidade celular; expressão das proteínas sialoproteína óssea (BSP) e osteopontina (OPN); atividade de fosfatase alcalina (ALP); expressão dos genes ALP, colágeno tipo I (COL), osteocalcina (OC), OPN, osterix (OSX) e runt-related transcription factor 2 (RUNX-2); e a formação de matriz extracelular mineralizada. Os dados foram comparados por análise de variância (ANOVA) seguido pelo pós-teste Student- Newman-Keuls e o nível de significância adotado foi de 5%. Aos 7 dias, a viabilidade celular foi maior sobre a superfície Ti Nano/Col, comparada às outras superfícies, dentre as quais não foi detectada diferença estatisticamente significante. Houve um 11 aumento da atividade da ALP dos 7 para os 10 dias; aos 7 dias, a atividade da ALP foi menor na superfície Ti Usi em comparação às superfícies Ti Nano e Ti Nano/Col; e aos 10 dias a atividade da ALP foi maior nas células crescidas sobre a superfície Ti Nano/Col comparado às demais superfícies. A imunolocalização, tanto para a OPN aos 3 dias quanto para BSP aos 7 e 10 dias, foi maior nos grupos Ti Nano e Ti Nano/Col com marcações fortes por todo o citoplasma além de depósitos extracelulares adjacentes às células. A expressão dos genes marcadores osteoblásticos avaliados foi maior sobre as superfícies Ti Nano e Ti Nano/Col, em comparação com as superfícies Ti Usi e Ti Usi/Col. A formação de matriz mineralizada foi maior nas superfícies Ti Usi/Col e Ti Nano/Col em relação às superfícies Ti Usi e Ti Nano, dentre as quais não foi detectada diferença estatisticamente significante. Esses resultados sugerem que a combinação de nanotopografia com revestimento com colágeno de superfícies de Ti estimula os eventos intermediários da osteogênese e tem potencial para favorecer a osseointegração dos implantes de Ti. / In Implantology, titanium (Ti) is the material of choice for the manufacture of dental implants because of its excellent mechanical properties and biocompatibility. However, new strategies to modify the topography and biochemical composition of Ti surfaces have been tested in order to increase the biocompatibility of Ti. The combination of topographic changes at the nanoscale and coating with collagen type I has potential to increase and/or accelerate the osseointegration process. The aim of this study was to evaluate the effect of Ti surface with nanotopography coated with collagen on in vitro osteogenesis. For this, osteoblasts harvested from rat calvaria were cultured in osteogenic medium on 4 Ti surfaces: machined (Ti Usi), machined coated with collagen (Ti Usi/Col), nanotopography (Ti Nano) and nanotopography coated with collagen (Ti Nano/Col). The osteogenesis was evaluated using the following parameters: cell viability; expression of bone sialoprotein protein (BSP) and osteopontin (OPN); Alkaline phosphatase (ALP) activity; gene expression of ALP, type I collagen (COL), osteocalcin (OC), OPN, osterix (OSX) and runt-related transcription factor 2 (RUNX-2); and the formation of mineralized extracellular matrix. Data were compared by analysis of variance (ANOVA) followed by Student-Newman-Keuls post-test and the significance level was set at 5%. At 7 days, cell viability was higher on the Ti Nano/Col compared 13 to other surfaces, among which was not detected statistically significant differences. There was an increase in ALP activity from 7 to 10 days; at 7 days, the activity of ALP was lower in Ti Usi surface compared to Ti Nano and Ti Nano/Col surfaces; and at 10 days the activity of ALP was higher in cells grown on the Ti Nano/Col surface compared to other surfaces. The immunolocalization to both OPN at 3 days and BSP at 7 and 10 days was higher in Ti Nano and Ti Nano/Col surfaces with strong labeling throughout the cytoplasm as well as extracellular deposits. The expression of the osteoblast marker genes was higher on Ti Nano and Ti Nano/Col surfaces compared to Ti Usi and Ti Usi/Col surfaces. The formation of mineralized matrix was higher in Ti Usi/Col and Ti Nano/Col surfaces than in Ti Usi and Ti Nano between which there was no statistically significant difference. These results suggest that the combination of nanotopography with collagen in Ti surfaces stimulates the intermediate events of the in vitro osteogenesis and seems to have potential to promote osseointegration of Ti implants.

O laser é uma fonte de radiação não ionizante altamente concentrada que em contato com diferentes tecidos resulta, de acordo com o tipo de laser, em efeitos térmicos, fotoquímicos e não lineares. Atualmente, o laser tem sido rotineiramente empregado em diversas áreas da ciência, assim como na Medicina e Odontologia. Os tratamentos com utilização de radiação a laser de baixa intensidade na odontologia são de grande interesse para as áreas de cirurgia buco-maxilo-facial e implantodontia sendo usado para a estimulação do processo de osteogênese. Um novo tratamento promissor envolve o processo fotodinâmico e emprega a combinação de dois agentes terapêuticos: um fármaco fotossensível e uma baixa dosagem de luz visível que combinados em presença de oxigênio provocam a bioestimulação celular. É um método eficiente, não-invasivo. Avaliar a utilização do fármaco fotossensível derivado das ftalocianinas com a ftalocianina de cloro-alumínio para o uso no tratamento para estimulação da osteogênese é o objetivo deste trabalho, será avaliado também a potencialidade terapêutica do processo. Na tentativa de se obter melhores resultados com esses fármacos, tem surgido nos últimos anos um interesse muito grande no desenvolvimento de formulações nanoestruturadas, dentro de uma linha altamente emergente de pesquisa a Nanobiotecnologia. Neste contexto, surge dentre os vários sistemas de veiculação disponíveis, as nanoemulsões, que permitem solubilizar fármacos hidrofóbicos em água, mantendo suas características físico-químicas. / The laser is a source of non ionizing radiation highly concentrated and coherent that in contact with different tissues induce thermal, photochemical and non-linear effects according to the type of the laser. Currently, the laser has been used routinely in many areas of science, as well as in medicine and dentistry. The treatments using laser radiation of low intensity in dentistry are of great interest specially in the areas of surgery bucco-maxillo-facial and dental implants and its being used to stimulate the process of osteogenesis. A promising new treatment in dentistry area involves the photodynamic process and employs a combination of two therapeutic agents: a photosensitizers drug and a low dose of visible light that combined in the presence of oxygen could induce cellular biostimulation. It is an efficient non-invasive method. Evaluate the use of the drug derived system to administrate photosensitizers as phthalocyanine derivatives chlorine-aluminum specifically for the use in treatment and stimulation of the osteogenesis is the main objective of this work. It will be also evaluated the therapeutic potential of the process. In an attempt to obtain better biocompatibility of these drugs it has developed in recent years an additional interest in the development of nanostructured formulations, focused in a highly emerging line of research the Nanobiotechnology. The nanoemulsion formulation was selected to this work. It was showed that the hydrophobic drugs choose for this work maintaining its photophysical and chemical characteristics in this medium applicable to biological tissue.

O tratamento das lesões ósseas cavitárias com autoenxerto ainda é considerado o padrão-ouro. Seu uso, entretanto, é limitado, devido principalmente à baixa disponibilidade e à morbidade do sítio doador. Os enxertos ósseos sintéticos são estudados com o objetivo de superar as limitações decorrentes da retirada de autoenxerto ou da disponibilidade de bancos de tecidos. O vidro bioativo é um material sintético osteoindutor, osteocondutor e antibacteriano, à base de sílica e cria um arcabouço para o crescimento ósseo. Objetivo: comparar o vidro bioativo com o autoenxerto, com relação às características histomorfométricas. Métodos: foi realizado um estudo experimental prospectivo caso-controle em animais, para comparar o vidro bioativo com o autoenxerto com relação às características histomorfométricas. Oito coelhos foram submetidos a uma cirurgia em que um defeito cavitário foi criado em ambos os fêmures proximais; de um lado, o defeito ósseo criado foi preenchido com os grânulos de vidro bioativo; do outro, o defeito ósseo foi preenchido com o autoenxerto retirado do lado contralateral. Os lados foram randomizados. Catorze dias após a cirurgia os animais foram sacrificados. Resultados: a análise histológica revelou que a neoformação óssea entre os dois grupos foi equivalente, e que a contagem de osteoblastos foi superior nos fêmures tratados com vidro bioativo. A contagem de osteócitos, por outro lado, foi menor. A semelhança na intensidade de neoformação óssea coincide com o encontrado na literatura. As diferenças de contagem celular são concordantes com o mecanismo de ação do vidro bioativo: aumento do turnover ósseo, estímulo dos osteoblastos e retardo na sua diferenciação para osteócitos. Conclusão: o vidro bioativo promove neoformação óssea semelhante ao autoenxerto neste modelo animal de defeito ósseo cavitário. Nível de evidência III, estudo caso-controle / Autograft is still considered the gold standard in the treatment of cavitary bone lesions. The low availability and donor site morbidity, however, limits its use. Synthetic bone grafts have been studied in order to overcome the limitations of autograft or allograft. Bioactive glass is an osteoinductive, osteoconductive and antibacterial silica-based synthetic material. It promotes the creation of a scaffold for bone growth. Objectives: to compare bioactive glass and autograft regarding their histomorphometric characteristics. Methods: the author conducted a prospective case-control experimental study on animals, to compare the histomorphometric characteristics of bioactive glass versus autograft. Eight rabbits underwent surgery in which a cavitary defect was created in both proximal femurs. On one side, the bone defect was filled with bioactive glass granules and on the other, the defect was filled with autograft grafted from the contralateral side. The sides were randomized. Fourteen days after surgery, the animals were euthanized. Results: histologic analysis revealed that bone neoformation was equivalent among the two groups and the osteoblasts cell-count was higher in the femurs treated with bioactive glass. The osteocytes cell-count, however, was lower. The similarity in bone formation between both groups was also found in the literature. The differences in cell-count of osteocytes and osteoblasts are in accordance with the mechanism of action of the bioactive glass: increase in bone turnover, stimulation of osteoblasts and inhibition of their differentiation into osteocytes. Conclusion: bioactive glass is similar to autograft regarding bone neoformation, in this animal model of cavitary bone defects. Level of evidence III, case-control study

by Yeung Hiu Yan. / Thesis (M.Phil.)--Chinese University of Hong Kong, 1999. / Includes bibliographical references (leaves 158-171). / Abstracts in English and Chinese. / ACKNOWLEDGEMENT --- p.i / ABBREVIATIONS --- p.ii / ABSTRACT (English & Chinese) --- p.iii / TABLE OF CONTENT --- p.viii / INDEX FOR FIGURES --- p.xii / INDEX FOR TABLES --- p.xvi / Chapter 1. --- INTRODUCTION --- p.2 / Chapter 1.1. --- History of Distraction Osteogenesis --- p.3 / Chapter 1.2. --- Clinical Application of Distraction Osteogenesis --- p.5 / Chapter 1.2.1. --- Limb-Lengthening --- p.5 / Chapter 1.2.2. --- Correction of Deformities and Non-Unions --- p.5 / Chapter 1.2.3. --- Bone Transport --- p.6 / Chapter 1.2.4. --- Reconstruction of the mandible --- p.7 / Chapter 1.3. --- Bone-specific Alkaline Phosphatase (BALP) --- p.8 / Chapter 1.4. --- Osteocalcin --- p.9 / Chapter 1.5. --- Bone Growth Factors --- p.11 / Chapter 1.6. --- Fibroblast Growth Factors (FGFs) --- p.12 / Chapter 1.6.1. --- Acidic Fibroblast Growth Factor (aFGF) --- p.13 / Chapter 1.6.2. --- Basic Fibroblast Growth Factor (bFGF) --- p.14 / Chapter 1.7. --- Transforming Growth Factor-pi (TGF-β1) --- p.16 / Chapter 1.8. --- Fracture Healing --- p.18 / Chapter 1.8.1. --- Histology --- p.18 / Chapter 1.8.2. --- Growth Factor Expression --- p.18 / Chapter 1.9. --- Distraction Osteogenesis --- p.19 / Chapter 1.9.1. --- Histology --- p.19 / Chapter 1.9.2. --- Growth Factor Expression --- p.20 / Chapter 1.10. --- Aim of the Study --- p.21 / Chapter 2. --- METHODOLOGY --- p.23 / Chapter 2.1. --- Animal Model --- p.23 / Chapter 2.1.1. --- Source of Animal --- p.23 / Chapter 2.1.2. --- Animal Operation --- p.23 / Chapter 2.1.3. --- Fracture Healing Model --- p.24 / Chapter 2.1.4. --- Distraction Osteogenesis Model --- p.24 / Chapter 2.2. --- Sample Collection --- p.25 / Chapter 2.2.1. --- Tissue Sample Collection and Preparation --- p.25 / Chapter 2.2.1.1. --- Test for the Complete Decalcification of the Calluses --- p.26 / Chapter 2.2.2. --- Blood Sample Collection and Storage --- p.26 / Chapter 2.3. --- Bone Mineral Density Measurement of the Distracted Callus and the Fracture Callus --- p.27 / Chapter 2.3.1. --- Fracture Healing Group --- p.27 / Chapter 2.3.2. --- Distraction Osteogenesis Group --- p.28 / Chapter 2.4. --- Serum Bone Specific Alkaline Phosphatase (BALP) Activity --- p.28 / Chapter 2.4.1. --- Wheat Germ Lectin (WGL) Precipitation of BALP --- p.28 / Chapter 2.4.1.1. --- Reagent --- p.28 / Chapter 2.4.1.2. --- Preparation and Measurement of Samples --- p.29 / Chapter 2.4.1.3. --- Auto-analyzer Setup --- p.30 / Chapter 2.5. --- Quantification of the Osteocalcin in Serum --- p.30 / Chapter 2.5.1. --- Reagent and Sample Preparation --- p.31 / Chapter 2.5.2. --- Detection Procedures --- p.31 / Chapter 2.6. --- Localization of the Growth Factors in Distraction Osteogenesis and Fracture Healing --- p.32 / Chapter 2.6.1. --- Immunohistochemistry of the Growth Factors --- p.33 / Chapter 2.6.1.1. --- Reagents and Solution Preparation --- p.33 / Chapter 2.6.1.2. --- Experimental Procedure --- p.36 / Chapter 2.6.1.3. --- Evaluation of Immunohistochmical Staining Results --- p.37 / Chapter 2.6.2. --- Verification of the Primary Antibody Used in the Study --- p.37 / Chapter 2.6.2.1. --- Tissue Preparation --- p.37 / Chapter 2.6.2.2. --- Antibody to Acidic Fibroblast Growth Factor (aFGF) --- p.38 / Chapter 2.6.2.2.1. --- Immunohistochemistry of Goat Brain and Growth Plate --- p.38 / Chapter 2.6.2.2.2. --- Dot Blot --- p.38 / Chapter 2.6.2.2.2.1. --- Materials and Reagents --- p.38 / Chapter 2.6.2.2.2.2. --- Procedures --- p.39 / Chapter 2.6.2.2.3. --- Sodium Dodecylsulphate Polyacrylamide Gel Electrophoresis (SDS-PAGE) --- p.41 / Chapter 2.6.2.2.3.1. --- Materials and Reagents --- p.41 / Chapter 2.6.2.2.3.2. --- Procedures --- p.42 / Chapter 2.6.2.2.4. --- Western Blotting --- p.43 / Chapter 2.6.2.2.4.1. --- Materials and Reagents --- p.43 / Chapter 2.6.2.2.4.2. --- Procedures --- p.44 / Chapter 2.6.2.3. --- Antibody to Basic Fibroblast Growth Factor --- p.45 / Chapter 2.6.2.4. --- Antibody to Transforming Growth Factor-β1 --- p.45 / Chapter 3. --- RESULTS --- p.53 / Chapter 3.1. --- Animal Model --- p.53 / Chapter 3.1.1. --- Fracture Healing Animal Model --- p.53 / Chapter 3.1.1.1. --- Radiography of Fracture Healing --- p.53 / Chapter 3.1.2. --- Distraction Osteogenesis Animal Model --- p.54 / Chapter 3.1.2.1. --- Gross Morphology of Distraction Osteogenesis --- p.54 / Chapter 3.1.2.2. --- Radiography of Distraction Osteogenesis --- p.55 / Chapter 3.2. --- Bone Mineral Density (BMD) Measurement --- p.56 / Chapter 3.2.1. --- In Fracture Healing --- p.56 / Chapter 3.2.2. --- Distraction Osteogenesis --- p.57 / Chapter 3.3. --- Bone-specific Alkaline Phosphatase Activity in Goat Serum --- p.59 / Chapter 3.3.1 --- ", Fracture Healing" --- p.59 / Chapter 3.3.2. --- Distraction Osteogenesis --- p.59 / Chapter 3.4. --- Serum Osteocalcin Measurement --- p.60 / Chapter 3.4.1. --- Fracture Healing --- p.60 / Chapter 3.4.2. --- Distraction Osteogenesis --- p.60 / Chapter 3.5. --- Histology --- p.61 / Chapter 3.5.1. --- Fracture Healing --- p.61 / Chapter 3.5.2. --- Distraction Osteogenesis --- p.64 / Chapter 3.6. --- Verification of Primary Antibody Used in the Study --- p.67 / Chapter 3.6.1. --- Antibody to Acidic Fibroblast Growth Factor --- p.67 / Chapter 3.6.1.1. --- Dot Blot --- p.67 / Chapter 3.6.1.2. --- Western Blotting --- p.68 / Chapter 3.6.1.3. --- Immunohistochemistry of Goat Brain and Growth Plate --- p.68 / Chapter 3.6.2. --- Antibody to Basic Fibroblast Growth Factor --- p.69 / Chapter 3.6.2.1. --- Dot Blot --- p.69 / Chapter 3.6.2.2. --- Immunohistochemistry of Goat Brain and Growth Plate --- p.69 / Chapter 3.6.3. --- Antibody to Transforming Growth Factor-β1 --- p.70 / Chapter 3.6.3.1. --- Western Blotting --- p.70 / Chapter 3.6.3.2. --- Immunohistochemistry of Growth Plate --- p.70 / Chapter 3.7. --- Localization of Growth Factors in Fracture Healing and Distraction Osteogenesis --- p.70 / Chapter 3.7.1. --- Acidic Fibroblast Growth Factor --- p.71 / Chapter 3.7.1.1. --- Fracture Healing --- p.71 / Chapter 3.7.1.2. --- Distraction Osteogenesis --- p.72 / Chapter 3.7.2. --- Basic Fibroblast Growth Factor --- p.73 / Chapter 3.7.2.1. --- Fracture Healing --- p.73 / Chapter 3.7.2.2. --- Distraction Osteogenesis --- p.74 / Chapter 3.7.3. --- Transforming Growth Factor-β1 --- p.75 / Chapter 3.7.3.1. --- Fracture Healing --- p.75 / Chapter 3.7.3.2. --- Distraction Osteogenesis --- p.76 / Chapter 4. --- DISCUSSION --- p.142 / Chapter 4.1. --- The Biochemical Events in Fracture Healing --- p.142 / Chapter 4.2. --- The Biochemical Events in Distraction Osteogenesis --- p.147 / Chapter 4.3. --- Limitations of the present study --- p.153 / Chapter 4.4. --- Future Study --- p.154 / Chapter 5. --- CONCLUSION --- p.156 / BIBLIOGRAPHY --- p.158

Chan Chun Wai. / "August 2004." / Thesis (Ph.D.)--Chinese University of Hong Kong, 2004. / Includes bibliographical references. / Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Electronic reproduction. Ann Arbor, MI : ProQuest Information and Learning Company, [200-] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Mode of access: World Wide Web. / Abstracts in English and Chinese.

Made available in DSpace on 2014-06-11T19:31:06Z (GMT). No. of bitstreams: 0 Previous issue date: 2006-02-06Bitstream added on 2014-06-13T19:40:59Z : No. of bitstreams: 1 leles_jlr_dr_araca.pdf: 1159504 bytes, checksum: bec692179cdbbe9f9b34ee0da4cdcfc8 (MD5) / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) / Há grande interesse no desenvolvimento de meios para manutenção ou recomposição alveolar visando a instalação de implantes osseointegráveis. No presente estudo o processo de reparo alveolar após implante de vidro bioativo (Biogran®) foi avaliado histologicamente. Quatro macacos-prego (Cebus apella) adultos tiveram seus incisivos superiores extraídos e os alvéolos preenchidos com vidro bioativo - Biogran® (Grupo Tratado, n=6 alvéolos) ou por coágulo sangüíneo (Grupo Controle, n=4 alvéolos). Aos 100 dias pós-operatórios os animais foram sacrificados e os espécimes removidos para processamento histológico. Observou-se que os alvéolos do Grupo Controle apresentavam tecido ósseo maduro distribuído irregularmente em trabéculas esparsas com grandes espaços medulares. Já no Grupo Tratado, encontravam-se preenchidos por uma rede de tecido ósseo neoformado com configuração lamelar e ampla ocupação alveolar. Os poucos fragmentos remanescentes do material foram vistos rodeados por tecido conjuntivo ou em contato direto com o tecido ósseo. Concluiu-se que o implante intra-alveolar de vidro bioativo favoreceu a neoformação óssea, atuando como agente osteocondutor. / Maintenance or reconstruction of alveolar process is a topic of great interest in oral rehabilitation with implants. The aim of this study was to investigate the histological features of alveolar wound healing in dental sockets grafted with bioactive glass. Four adult capuchin monkeys (Cebus apella) have their incisor teeth extracted and alveolus filled with particulate bioactive glass Biogran® (Test Group: n=6 alveolus) or blood coagulum (Control Group: n=4 alveolus). After 100 days, animals were sacrificed and specimens removed for histological processing. It was observed that Control Group presented mature neoformed bone irregularly distributed in few trabeculas with large medullar spaces. Alveolus of Test Group were filled with a net of lamellar neoformed bone. The few remaining particles of bioactive glass were surrounded by connective tissue or in close contact with bone tissue. It was concluded that intra-alveolar bioactive glass improved bone neoformation by osteoconductive action.

Though it is well known that tobacco related products can cause prenatal maldevelopment, very little is known on how tobacco products affect bone tissue as it develops in the embryo. Identifying which chemicals can induce the greatest harm to the prenatal skeletal system is an improbable task as there are over 7,000 chemicals in tobacco smoke alone. We hypothesized that the Toxicological Priority Index (ToxPI) program can be used to rank osteogenic cytotoxicity potential to aid in the assessment of what chemicals out of the thousands can cause osteogenic differentiation inhibition. ToxPI aggregates information from various assays and incorporates them into visual “pie charts” which allow chemicals to be ranked against each other by given parameters. The larger the pie chart the greater likelihood of potential effects and vice versa. Seventeen tobacco chemical constituents were ranked using ToxPI and those chemicals with pie charts (0 To assess the ability of ToxPI to correctly predict maldevelopment in silico eight compounds were then tested in vitro: four of them being ToxPi positive and the other four having null predicted effects. To verify the predictions, human embryonic stem cells were differentiated into osteoblasts and exposed to various concentrations of each compound. Cell viability was measured via MTT assay in conjunction with a calcium assay to measure osteogenic differentiation. In addition, adult human feeder fibroblasts cell viability in response to exposure was measured. ToxPI positive predictions (xin vitro, caused differentiation inhibition. Together our data suggests that ToxPi might be useful to identify strongly inhibitory chemicals based on their cytotoxicity but might also give false negative results for chemicals that cause differentiation inhibition at sub-toxic levels.

No description available.

Diss. (sammanfattning) Stockholm : Karolinska institutet, 2007. / Härtill 5 uppsatser.